Objective: Women are often exposed to various medications and medical conditions during pregnancy. Unrealistically high maternal teratogenic risk perception, related to these exposures, may lead to abrupt discontinuation of therapy and (or) termination of a wanted pregnancy. The association between maternal depression and the teratogenic risk perception has not been studied, nor were the actions resulting from this perception. Our objectives were to explore the association between maternal depression, teratogenic risk perception, and the rated likelihood to terminate pregnancy. Additionally, we evaluated possible benefits of counselling.
W omen are often exposed to various medications and medical conditions during pregnancy. Teratogenic risk perception related to such exposures is often unrealistically high among pregnant women. [1] [2] [3] [4] This may result in discontinuation of treatment for even life-threatening medical conditions 1 or termination of an otherwise wanted pregnancy when exposure occurs. [2] [3] [4] [5] Sudden discontinuation of medications during pregnancy may lead both to withdrawal symptoms, as well as to re-emergence of the primary disorder. 6 In previous work, 2 we have assessed the perception of teratogenic risk by 80 women attending an antenatal consultation service for different exposures in pregnancy. Women exposed to agents not known to be teratogenic assigned themselves a significantly higher risk for fetal major malformation before the relevant medical literature was delivered. These women accurately estimated their personal risk for major malformation following the counselling session. The rated likelihood to terminate pregnancy (when exposed to a nonteratogen) significantly decreased after the consultation.
Perception of teratogenic risk and maternal decision-making are likely to be influenced by multiple factors including maternal emotional state. Depression in women peaks during the childbearing years and can occur in up to 15% of all women. 7, 8 Untreated depression in pregnancy has been associated with poor maternal health, hospitalization, suicide ideation and attempts, and life-threatening postpartum depression. 9, 10 It is also associated with an increased risk of miscarriages and preterm births. [10] [11] [12] Maternal depression is often undiagnosed or undertreated thereby exposing women and fetuses to these adverse outcomes. 13 In women with depressive symptoms and undiagnosed depression, neither their perception of exposure-related teratogenic risk nor their intentions and actions in response to these perceptions have been studied. Our objectives were to explore factors affecting maternal perception of teratogenic risk and the rated likelihood to terminate a pregnancy, specifically with relation to their depressive symptoms. Possible benefits of a single, exposure-related, counselling session were assessed as well.
Methods
The Motherisk Program is an information and counselling service for women and their health professionals on the safety or risk of drugs and other exposures during pregnancy and lactation. The process begins with an initial telephone conversation with a counsellor. Basic demographic information and details of the exposure are collected, and exposure-related counselling is provided. As part of the service, selected women are invited to our clinic where they are counselled about more complicated exposures and chronic maternal conditions. Such a clinic session is booked if the Motherisk counsellor feels the exposure or medical background of the caller are complicated or if the caller requests it. These women may have either exposure to multiple drugs, a chronic medical condition that may affect the pregnancy, or a possible teratogenic exposure. Nevertheless, many of the women are booked for a clinic visit simply owing to their desire to be personally counselled by a professional in the field.
During the hour-long counselling session, held by a physician, a detailed medical history and demographic questionnaire is completed and evidence-based information pertaining to the specific exposure is discussed in detail. Exposure-related teratogenic potential as well as risks and benefits of therapy during pregnancy are explained to ensure the patient will make informed decisions. Other demographic factors, such as maternal age and ethnicityrelated risks, are also discussed.
As a part of the counselling session we routinely measure the woman's perception of teratogenic risk as well as her likelihood to continue or terminate the current pregnancy, before and after counselling, using validated tools. 2 At the beginning of the interview, women are requested to provide an estimate of the teratogenic risk related to their specific exposure using our validated 10 cm VAS. 2 This task is completed by assigning a number to the perceived risk for fetal major malformations between 0 (no risk) and 100 (100% risk), which is marked on a scale. Patients are then asked for an opinion as to what they feel is the risk for major malformations in the general population, followed by a question regarding their rated likelihood to terminate or continue the pregnancy, if currently pregnant. The pregnant women are asked: "If zero means you are certain that you will keep the pregnancy and 100 means that you are certain that you will terminate this pregnancy, what do you feel your intentions are?-and I do not suggest either way." Women are asked to express their own opinions and not to answer the questionnaire in a way they feel may please the interviewer. These 3 questions are repeated at the end of the counselling session. The counselling session is similar whether the woman is already pregnant or planning a pregnancy. The rated likelihood to terminate the pregnancy is evaluated only in women that are already pregnant at the time of counselling. Some of the women have difficulty in estimating their personal risk perception and (or) quantifying their rated likelihood to terminate the pregnancy but, generally, the response rate is over 70%. were considered eligible, whether pregnant or planning a pregnancy. As described earlier, the only difference between the pregnant and nonpregnant subgroups was the question regarding the rated likelihood for termination of pregnancy, which was addressed to the pregnant subgroup only. The EPDS questionnaire was checked and scored by the attending physician following the counselling session. Confidentiality was maintained by the use of study code numbers, and all procedures were approved by our institutional review board.
The EPDS is a 10-item self-rating scale developed by Cox et al 14 in 1987 for detection of postpartum depression. The EPDS was later validated for use during pregnancy. [15] [16] [17] [18] Although not a diagnostic tool, per se, an EPDS score of 13 or more is widely used to indicate probable major depressive disorder.
The medical records of all women who attended the Motherisk clinic at The Hospital for Sick Children between October 2007 and April 2010 were reviewed. We reviewed data collected during the initial telephone conversation with the counsellor, as well as all the data collected during the clinic session. This included details of maternal demographics, medical background and drug exposures, the EPDS score, perception of personal (exposure-related) and general teratogenic risk, and the rated likelihood to terminate the pregnancy prior to, and following, the counselling session.
Women were considered to be suffering from diagnosed depression if at least one of the following conditions was fulfilled: their referring health care provider stated so in the referral letter, or if a prescription for an AD was given to them by a physician, for this purpose.
Assessment of the counselling intervention was a secondary objective of our study. We have used the 3 questions described above (rate of major malformations in the general population, personal risk perception, and rated likelihood to terminate the pregnancy) before and after the counselling to compare the effect of counselling itself on maternal knowledge and intentions.
Data Analysis
Statistical analysis was performed with the use of SPSS software, version 18 (SPSS Inc, Chicago, IL). Data are presented as proportions with 95% confidence intervals and (or) means or medians where appropriate. Associations between the EPDS score and maternal perception of teratogenic risk, as well as the rated likelihood to terminate the pregnancy, were assessed. VAS scores (of the 3 questions described above) prior to, and following, counselling were compared using the Wilcoxon correlation test. VAS and EPDS scores were compared between different maternal demographic and medical subgroups using the Mann-Whitney U test based on the normality of data distribution. Spearman and Wilcoxon correlations were used to compare continuous variables. Simple and multiple regression analyses were performed, to account for confounders, for identifying correlation between different variables, risk perception, and rated likelihood to terminate the pregnancy. In the multiple regression analysis, we have included all the variables that were significant in univariate analysis, as well as variables that we strongly suspected to have an effect on maternal perceptions and termination intentions. Variables included in the multivariable regression model were maternal age, marital status, planned compared with unplanned pregnancy, EPDS score, diagnosed depression, and exposure to teratogenic medications.
Results
We collected data on 413 women, 179 (43.3%) of whom were pregnant at the time. Over 97% (403/413) of all women approached agreed to complete the EPDS questionnaire. The study population consisted of mostly Caucasian, married, and highly educated women aged in their early 30s ( Table 1 ). Ten per cent of the women were aged 40 years or older, and 1.2% were 18 years or younger. About one-half of the women were pregnant, mostly (79%) in the first trimester, when attending the counselling session, and the rest were planning a pregnancy. The general perception of teratogenic risk and rated likelihood to terminate the pregnancy, if pregnant, are presented in Table 2 . Data are shown before and after the counselling session. Maternal response rate was 74.1%, 81.1%, and 74.3%, respectively, for the 3 questions presented in Table 2 . Both the perception of teratogenic risk and rated likelihood to terminate the pregnancy were significantly lower following the counselling session. Some demographic characteristics correlated significantly with the women's perception of teratogenic risk and the rated likelihood to terminate pregnancy (Table 3) . Women aged 35 years or older had significantly higher rated likelihood to terminate the pregnancy both before and following counselling (P = 0.04, for each). Older women (aged 40 years or older) had higher perceptions of teratogenic risk and single women had a higher rated likelihood to terminate the pregnancy. Maternal education had a significant effect on personal risk perception.
The perception of personal teratogenic risk was significantly correlated with the rated likelihood to terminate the pregnancy, both before and after counselling (P < 0.001).
Ninety-four women (22.7%) were exposed to potentially teratogenic medication (Table 1) . These women had a significantly higher perception of personal teratogenic risk (precounselling P < 0.001, postcounselling P = 0.001) and a higher rated likelihood to terminate the pregnancy (precounselling P = 0.04, postcounselling P = 0.08), compared with the rest of the study population.
Twenty-nine per cent of all women attending the clinic were previously diagnosed with depression. Among them, 86.4% were treated with ADs. Table 4 presents the correlation between EPDS scores in the general study population, use of ADs, and both risk perception and the rated likelihood to terminate the pregnancy. EPDS scores significantly and positively correlated with the rated likelihood to terminate the pregnancy. Use of ADs were associated with a trend toward lower risk perception and less-rated likelihood to terminate pregnancy in the depressed subgroup, although this did not reach statistical significance (Table 4 ).
In a multivariable regression analysis (including maternal age, marital status, planned compared with unplanned pregnancy, EPDS score, diagnosed depression, and exposure to teratogenic drugs) an EPDS score of 13 or more was found to be an independent predictor of a higher personal teratogenic risk perception before counselling (P = 0.03).
The following factors were found to significantly correlate with the rated likelihood to terminate the pregnancy in a multivariable regression analysis (either before or after the counselling session): age (P = 0.03), marital status (P = 0.002), unplanned compared with planned pregnancy (P = 0.001), and diagnosed maternal depression (P = 0.01).
Discussion
Over the years, overestimation of the potential teratogenic effects of various exposures in pregnancy has become apparent. Women tend to assign an unrealistically high teratogenic risk to medications not known to be teratogenic, or even to some that have been proven to be safe. 1, 2, 4 As a result, misperception may sometimes lead to termination of an otherwise wanted pregnancy. 19, 20 In a previous publication 2 by our group, analysis of the first 80 patients for whom the VAS was used revealed the power of this tool in detecting misperception and misinformation in a maternal population primarily exposed to nonteratogenic drugs.
We have compared maternal answers with the 3 VAS questions described in the methods section (general rate of major malformations in the population, personal risk perception, and rated likelihood to terminate the pregnancy), before and after counselling, to explore possible effects of counselling on maternal knowledge and intentions. The perception of personal teratogenic risk, and the rated likelihood to terminate the pregnancy, were significantly influenced by the counselling intervention. Following the counselling session, women estimated the general and personal teratogenic risk in a more realistic and evidencebased manner, and the rated likelihood to terminate the pregnancy was significantly lower ( Table 2 ). These findings are suggestive of a possible beneficial effect of counselling in reducing maternal fear of teratogenicity and possibly pregnancy termination. Nevertheless, this observation is merely a pre-post counselling comparison, with no separate control group. Thus results must be interpreted with caution.
Not surprisingly, several demographic characteristics were shown to affect the maternal risk perception and the rated likelihood to terminate a pregnancy. For example, older women had a higher rated likelihood to terminate the pregnancy and a higher risk perception following counselling. Part of our counselling session routinely addresses the significance of maternal age and its implications on the risk of chromosomal abnormalities. This Table 2 Perception of teratogenic risk and rated likelihood to terminate the pregnancy before and after the counselling session may partially explain the significantly higher risk assigned by women aged 40 years or older, when compared with younger women, despite receiving the same counselling about the specific exposure.
Data on whether a pregnancy was planned or not was available in 91 women only (50.8% of the pregnant study population). Among the women answering the question, 60 women (65.9%) replied that the pregnancy was unplanned. Many women were reluctant to answer the question. As only about one-half of the pregnant study population answered this question, it does not necessarily represent the entire group. Nevertheless, we included this factor in the statistical analysis because this is a potentially important factor affecting the decision to continue or terminate the pregnancy. The multivariate analysis demonstrated this variable to be significantly and independently associated with the rated likelihood of pregnancy termination (P = 0.001).
Maternal depression and its association with the perception of teratogenic risk, and the rated likelihood to terminate a wanted pregnancy is a critical yet neglected issue. We documented that an EPDS score of 13 or more independently correlated with an elevated teratogenic risk perception in the multiple regression model. Conversely, women with diagnosed and treated depression, had a lower rated likelihood to terminate their pregnancy, compared with the untreated depressed subgroup (although this did not reach statistical significance). These findings suggest a relation between depressive symptoms and teratogenic risk perception. The higher likelihood of pregnancy termination in the higher EPDS score group is possibly a result of the higher risk perception. Nevertheless, the limited group size and study methodology do not allow drawing conclusions regarding the possible effects of AD treatment on personal teratogenic risk perception and the likelihood of pregnancy termination.
Our study has several strengths. The VAS tool for estimation of maternal risk perception and a mother's rated likelihood to terminate the pregnancy has previously been validated. 2 The questions are asked and answered in a face-to-face manner, with the patient and the counselling physician present in the room. The natural tendency of women to answer correctly or in a way she thinks will please others present in the room has been addressed in the manner of presenting the question. For example, the woman is asked: "If zero means no risk and 100 means that there is always a problem, where do you feel you are?-and I do not suggest you have a risk." We reported in a previous study that, following counselling, a response greater than 50% risk has a high indicative value of the women's actual decisions about postcounselling. 20 The occasional presence of family members during the counselling sessions may potentially have an influence on the woman's perceived risk and rated likelihood to terminate a pregnancy, as it would in real life.
We have used the validated EPDS to quantify depressive symptoms. To our knowledge, no previous study has A potential limitation of our study is the specific nature of the population using our services, which does not necessarily reflect the general population of pregnant women, as these women have a higher socioeconomic status than average (Table 1) , and are a selected group invited to a clinic owing to complicated exposures. Nevertheless, only 22.7% of the study population was actually exposed to potentially teratogenic medication.
Study group size is another limitation. Some of our results showed a tendency toward an association, but this did not reach statistical significance. We believe that a larger group size would have demonstrated the associations between depressive symptoms and maternal perceptions and intentions in an even more convincing manner.
Generalizability of our findings has to be confirmed, although it is plausible that the effects of depressive symptoms (assessed by the EPDS questionnaire) on maternal perception may be independent of other demographic and medical factors, as shown in the multivariable analysis.
Conclusions
Maternal depression, both diagnosed or not, appears to be significantly associated with maternal exposure-related risk perception and the rated likelihood to terminate the pregnancy. Our findings also suggest a beneficial role to counselling regarding different exposures in pregnancy. 
